CVS management, board have been weighing options for months

By Cynthia Koons and Fiona Rutherford
Published 5 Min Read

Bloomberg Mercury

CVS has been reviewing its strategic options for months, including a potential breakup, according to a person familiar with the talks, as rising medical costs in its Aetna insurance arm weigh on the health-care conglomerate. 

The entrance of hedge fund Glenview Capital Management, which approached the company a few weeks ago about improving the business, made the conversation public and ratcheted up pressure on CEO Karen Lynch. 

Cynthia Koons and Fiona Rutherford

For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form